In vitro antifungal activity of the sulphonamide and carbamate derivatives of Nebivolol intermediate (8a–g & 9a–d).

Compound	MIC in μg mL−1
	Aspergillus niger	Aspergillus flavus	Rhizopus arrhizus
Fluconazole	19.40 ± 0.17	18.38 ± 0.32	22.32 ± 0.45
8a	22.32 ± 0.27	23.06 ± 0.25	22.80 ± 0.54
8b	20.40 ± 0.87	17.81 ± 0.16	20.21 ± 0.65
8c	18.10 ± 0.46	16.72 ± 0.70	22.22 ± 0.83
8d	15.30 ± 0.15	17.04 ± 0.70	18.65 ± 0.65
8e	11.71 ± 0.35	14.08 ± 0.55	16.64 ± 0.52
8f	15.66 ± 0.69	16.18 ± 0.82	19.04 ± 0.20
8g	14.06 ± 0.72	15.18 ± 0.80	14.36 ± 0.66
9a	11.20 ± 1.08	12.66 ± 0.80	14.18 ± 0.69
9b	24.72 ± 0.70	23.81 ± 0.67	19.24 ± 0.48
9c	19.32 ± 0.47	19.81 ± 0.37	25.56 ± 0.48
9d	28.46 ± 0.14	25.20 ± 0.66	31.28 ± 0.45